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ABSTRACT
This study focuses on the development of a new paper‐based microfluidic device
for the detection of IαIP via ELISA. Recent studies proved that the concentration of
IαIP is related to the mortality rate of patients who suffer from sepsis. The developed
device is able to determine the concentration of IαIP in a buffer solution where a low
concentration is an indicator for sepsis. Using a microfluidic valve, the reagents
needed to perform the ELISA can be loaded sequentially. The microfluidic device
consists of paper on which the channel geometry is printed with wax ink. Different
layers of the device are stacked together with double sided tape where paper is
biodegradable. After applying the reagents, the device produces the results
autonomously in form of a colored dot. The intensity of the dot is linked to the
concentration of the target analyte IαIP. Two methods to distinguish the
concentration of IαIP were conducted to decide which method is more appropriate
for this experiment. After optimizing the reagents with regards to reproducibility,
optimal signal to noise ratio and sensitivity a standard curve is produced that links
the intensity of a color dot to a concentration of IαIP. Compared to other methods
like a blood test which needs 48 hours to deliver a result or microtiter‐plates which
need large fluid volumes, the microfluidic paper device is able to obtain a result
within minutes as well as it uses smaller fluid volumes.
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CHAPTER 1 ‐ Introduction
This chapter provides background knowledge for the reader on various Paper

Based point of care Devices (PBD) like Lateral Flow Devices (LFD), μPads and Enzyme‐
Linked‐Immunoassays (ELISA’s). Also, the principles of general immunoassay tests are
explained. Furthermore, the importance of sepsis detection and the role of Inter‐
alpha inhibitor protein is discussed.
1.1

Sepsis an Introduction
The word sepsis has its origin in the Greek language with Sepsis (greek. σῆψις)

meaning putrefaction and decay. It is a health problem in developing countries as
well as in the industrialized world [1]. Sepsis is listed 13th in the top 15 International
Classification of Disease with a 39.6% ‐hospital mortality rate with 1.8% of all in‐
hospital deaths resulting from sepsis [2]. Septicemia therefore is a serious disease
and cause for lower life expectancy. Konrad Reinhart the chairman of the Global
Sepsis Alliance (GSA) said "Tens of millions of people die from sepsis each year,
making it the likely leading cause of death worldwide. Sepsis kills regardless of age,
ethnicity, location and access to care."
In many cases it is not trivial to recognize that a patient suffers from Sepsis, but it
is difficult to differentiate inflammation symptoms of the flu or other afflictions [1].
One method for characterization is to define the various stages of sepsis in the PIRO‐
scheme (Predisposition, Infection, Response and Organ dysfunction), which was
introduced in 1991. Each category is evaluated with 0 to 4 points with each point
1

representing an increase in the risk for mortality by 30%‐50% [3]. Many other
characterization schemes have also been established (e.g. Recombinant Human
Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) and
Promoting Global Research Excellence in Severe Sepsis (PROGRESS)). Unfortunately,
the existence of competing definitions makes it difficult to compare several
conditions or stages of sepsis [1].
In 2005 the international sepsis forum categorized the six most common
infections which can cause sepsis.

These included pneumonia, blood‐stream

infections, intra‐abdominal infections, urological infection and surgical wound
infection [4]. One new understanding is that bacteria release certain toxins (e.g.
endotoxin) in case of cases of gram‐negative sepsis, which attack certain organs and
several immune cells which then release mediators. Mediators can kill bacteria and
inactivate toxins but an inflammation is created as well [5].
The evolution from infection to a septic shock occurs quickly (couple of hours),
therefore, early detection and characterization is detrimental to reduce chances of
mortality. Therefore there is a need for a device that may rapidly detect sepsis [1].
1.2

The course of sepsis
An infection is called septic when a nidus which is a place in which bacteria have

multiplied, is formed in the body. It releases periodically pathogenic bacteria into the
human bloodstream. The pathogen causes subjective and objective complaints.
Subjective complaints are only noticeable by the affected person whereas objective
2

complaints are visible to other people as well [6]. Sepsis can be caused by many
different types of bacteria. Table 1‐1 is a summary of sepsis nidi and pathogens.
Table 1‐1: Nidi and pathogens of sepsis [7]

Organ
ear, nose and
throat area

Infection
Tonsillitis, sinusitis, otitis

Lung

pneumonia

intestine

Peritonitis

Biliary tract

Cholangitis

gynecological
area
Genitourinary
system

Postpartum sepsis or
arbortum

Skin

urinary infection
Wound infection, burned
skin

Typical pathogen
Streptococci, pneumococci and
meningococci, Bacillus fusiformis
Pneumococci, Haemophilus
influenzae
Salmonella, E. coli, enterococci
E. coli, Enterobacteriaceae,
anaerobes
Streptococci, Clostridium
perfringens
E. coli, enterococci, KlebsielIen,
Proteus, Pseudomonas
Staphylococci, streptococci, gram‐
negative bacteria (Pseudomonas)

Many organs could become a nidus of septic infection when several pathogens
are present. However, not all infectious nidi lead to sepsis. Although the issue is not
fully understood, one possible source might be from people who have a weakened
immune system as a result of recent surgery. The proportion of and aggressiveness of
a pathogen to the body’s defense also seems to be important in determining
whether a patient will develop sepsis or not [5].
Possible symptoms of sepsis are a body temperature more than 38 °C or less than
36 °C, a cardiac frequency over 90 beats/min, a respiratory frequency over 20
breaths/min and a leucocytes level higher than 12000/µg (leukocytosis) or less than
4000/µg (leucopenia). A patient is said to be septic when they have at least two out
3

of four symptoms. Due to the expansion of the peripheral vessels, blood pressure
decreases and a higher cardiac frequency may incur a septic shock. Therefore, if the
disease is not trated correctly, mortality will be imminent [5].
1.3

The role of Inter‐α‐Inhibitor proteins
Within the realm of paper‐based‐microfluidic device a possible target is Inter‐α‐

inhibitor‐proteins (IαIP). The IαIP belongs to the family of protein‐glycosaminoglycan‐
protein complexes (PGP). It was first discovered in the 1960’s and isolated from
human plasma. The IαIP is located in plasma also in urine [8]. It is named after the α‐
region through where it passed when an electrophoresis is performed [9]. In a
healthy organism the concentration in human plasma is 400‐800 mg/liter [10]. The
structure of IαIP is shown in Figure 1‐1.

Figure 1‐1: Inter‐α‐inhibitor proteins [8]

It consists out of two heavy chains. One is called heavy chain 1 and the other is
called heavy chain2 (HC1 and HC2). Additionally, a light chain (bikunin) linked with a
glycosaminoglycan chain (black and white chain) is present [8]. Many physiological
4

and pathological processes in the body are performed with the help of IαIP’s.
Inflammation, wound healing and stabilization of the extracellular matrix occur with
the mediation of IαIP’s [11].
IαIP’s are synthesized mainly in hepatocytes in the liver. The IαIP is needed later
on to form for example the Serum‐Derived Hyaluronan‐Associated‐Protein‐complex
(SHAP‐HA‐complex), which is present can be found in the synovial fluid in inflamed
knee joints. During an illness synthesis rate in the liver decreases by 20‐90% from its
original rate [12]. The synthesis of IαIP’s and the SHAP‐HA‐complex is shown in Figure
1‐2.

Figure 1‐2: Synthesis of IαIP and the SHAP‐HA complex [8]

5

Therefore bikunin and the two HC’s are linked together in the Golgi apparatus.
The three components of the IαIP have different tasks whereas the task of the heavy
chains is currently not fully understood [13]. Bikunin is responsible for the serine
protease inhibitory activity. Bikunin is inactive as long as it is bound in the protein
complex between the two heavy chains. In a proteolytic degradation the IαIP is split
into

smaller

polypeptides

(HC1,

HC2

and

bikunin)

and

amino

acids

(glycosaminoglycan chain) [11]
As explained earlier, the IαIP can fight inflammation. Hyaluronan is the main
glycosaminoglycan in synovial fluid. In a recent study, several probes were taken
from knee joints of patients who suffer from active rheumatoid arthritis, ie. people
who have a constant onset of inflammation. In comparison to normal synovial fluid
the rheumatoid fluid contained a higher amount of bound IαIP’s. The IαIP’s are linked
to Hyaluronan (HA) in a trans‐esterification to a SHAP‐HA‐complex [8]. This study
shows that the amount of IαIP’s decreases during an inflammation [14]. Several
studies were performed by Chaaban et. al. [12], Lim et. al. [14] and Opal et. al. [15] to
find a correlation of the concentration of IαIP in the plasma and the mortality rate of
a person who suffers from sepsis.
Opal et. al. [15] exposed lipopolysaccharide (LPS) activated peritoneal
macrophages to lethal toxin (LT) and varying concentrations of IαIP. The results of the
test are shown in Figure 1‐3.
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Figure 1‐3: Correlation between mortality rate and c(IαIP) in mice [15]

The survival percentage is plotted over the time. It can be seen that the
mortality rate is proportional to the level of lethal toxin. When IαIP is added to the
sample the mortality rate decreased. IαIP is proposed to affect the activity of furin an
enzyme which is important for the formation of lethal toxin. Furthermore the
presence of the monoclonal antibody 69.31 (MAb 69.31), which is used by Lim et. al.
[14] to immobilize IαIP increases the mortality rate again. The MAb 69.31 interacts
with bikunin the active site of the IαIP which possesses the protease inhibitor
function [15].
In the previous section experiments were performed on mice. Lim et. al. [14]
conducted experiments on blood samples from patients with sepsis. The IαIP was
immobilized with MAb 69.31 on a 96 well plate. Next a horseradish peroxidase (HRP)
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labeled AB was attached to the protein and the absorbance of light at 405 nm was
measured on an ELISA plate reader. Figure 1‐4 illustrates the correlation between the
concentration of IαIPs and the mortality rate.

Figure 1‐4: Correlation between mortality rate and c(IαIP) in humans [14]

The mortality rate decreases when the concentration of IαIP increases. During
severe sepsis the synthesis of many other proteins is disturbed. In addition systemic
proteolysis induces the degradation of IαIPs during sepsis. In contrast, patients with a
high level of IαIP in their blood are less likely to develop septic shock. These findings
show that IαIP’s are needed to effectively treat a septic patient [14].
Kaczmarczyk et. al. [9] points out the roles of IαIP during an inflammation.
Tumor necrosis factor‐inducible gene 6 protein (TSG‐6) in combination with IαIP
builds an extracellular matrix containing Hyaluronan. The reaction is illustrated in
Figure 1‐5.
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Figure 1‐5: Coating of extracellular matrix with Hyaluronan [9]

Hyaluronan usually binds to the cell surface receptor (CD44). From the split
IαIP the HC1 and the HC2 connect to hyaluronan. Bikunin is not involved in the
reaction. After the TSG‐6 molecule sticks to the HC’s and makes it possible that more
hyaluronan to bind to the cell surface. Crosslinking of hyaluronan molecules ends in a
stable structure [9]. This hyaluronan coat on the cell surface facilitates the cell
migration for leucocytes which improve the cure of inflamed tissues [16].
1.4

Enzymatic reactions on the chip
So far two different procedures have been proposed. These methods are

detection via ELISA or via immunosorbent assay. Of these, the assay which is more
promising for determining IαIP in a sample will be used. Both methods are explained
and discussed in the next section

9

1.4.1 Enzymatic or Inhibitory assay
On an immunosorbent surface, enzymes are immobilized which are able to
capture certain proteins. When a sample flows over this surface, some of the
proteins, for which the enzymes have an affinity, will be immobilized [17]. In the
proposed chip, trypsin enzymes are immobilized on the filter nitrocellulose to
capture the previously discussed IαIP. Those enzymes that have captured the
proteins are deactivated. Thus when the substrate flows over the test spot area, only
those enzymes which have not been deactivate by IαIP will produce the color
product. BAPNA is the substrate typically used for trypsin enzymes.
1.4.2 ELISA
An alternative method is by Enzyme Linked Immunosorbent Assay (ELISA). An
ELISA uses antibodies and a substrate, which causes a color change, to identify a
certain target analyte. The scheme of a common ELISA Test is displayed in Figure 1‐6.

Figure 1‐6: Scheme of an ELISA‐Test
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Capture antibodies are immobilized onto a surface such as the bottom of a
plastic well or a nitrocellulose membrane in case of a PBD. The in‐sample target
substance should bind to the capture antibody. In the next step, a detection antibody
which is tagged with an enzyme (Horseradish Peroxidase (HRP) or Alkaline
Phosphatase (ALP)), binds to the substance to form a complex that includes a capture
antibody‐target substance‐detection antibody sandwich. In the last step, a substrate
like 5‐Bromo‐4‐chloro‐3‐indolyl phosphate nitroblue tetrazolium (BCIP/NBT) for ALP
or 3,3′,5,5′‐tetramethylbenzidine (TMB) for HRP is added to induce a color change.
The ELISA sandwich assay is applicable to all types of antigens or proteins
which can be captured with a certain antibody. Following this step, a colored signal
can be produced using a substrate and a detection antibody tagged with an enzyme
to indicate the presence of a target substance. Föllscher et. al. [18] and Gerbers et.
al. [19] showed that their developed circuit is able to determine certain
concentrations of Rabbit IgG via a paper‐based ELISA. The example of Murdock et. al
[20] shows that many other target analytes can be detected using ELISA on paper. In
their case they detected various concentrations of neuropeptide Y (NYP).
1.5

Point of Care devices
In recent years there has been a growing interest in the field of paper‐based

devices. These devices are less complex and less expensive than previous gadgets
used for detection (e.g. an immunoassay test) [21]. The aim of this field of research is
to develop devices that satisfy the criteria of Point‐of‐Care devices (POC) and can be
11

used in developing countries where no medical infrastructure is present [22]. POC
devices have to be “ASSURED: affordable, sensitive, specific, user‐friendly, rapid,
robust, equipment free and deliverable for the end user [23]. An appropriate POC
device meets all of these requirements. One example is the device which is
introduced by Föllscher et. al. [18] and Gerbers et. al. [19].
The most common example for a POC‐device is the Lateral Flow Test (LFT). LFT’s
are an appropriate method to establish POC‐devices in developing countries because
e.g. they are cheaper than complex tests which need a lot of expensive
instrumentation [22]. Currently there are several lateral‐flow‐devices (LFD) on the
market. The most familiar LFD’s to the public are pregnancy tests, HIV tests and drug
tests [24]. As discussed before, all “ASSURED” criteria’s need to be fulfilled. A pape‐
based LFT is therefore a suitable choice because it meets these requirements.
Paper is available everywhere in the world. It is inexpensive compared to other
materials and furthermore it is biodegradable [23]. Also, it is biocompatible with all
of the reagents tested so far [25]. Most of the tests require expensive equipment to
read out the results of a specific test or a pump to maintain the fluid flow inside the
device. PBD do not need mechanical equipment such as a pump due to the capillary
flow; this further reduces the need for expensive additional equipment to run test
[26].
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1.6

Justification
A bacterial infection has to be treated with an antibiotic which is specific to the

infection present in the human body [27]. As explained earlier treatment of sepsis
has to be done as rapidly as possible. In order to detect the specific pathogen, a
diagnostic result that produces a result faster than the current tests (24‐48hrs) is
needed [28]. Unfortunately, according to Engel et. al. [29] the specific pathogen
which causes illness is correctly detected in only 57% of all cases. Almost every other
patient cannot be treated with a specific antibiotic. Therefore most of the patients
can be treated only with broad spectrum of non‐specific antibiotics, regardless if they
are certain to combat an infection or not. Due to the possible use of ineffective
antibiotics, the pathogen may develop a resistance against the antibiotics [30].
As one can see, the need for a faster detection method than offered by the
microbiological blood analysis has to be developed. This is especially necessary in half
the cases where the pathogen can be identified correctly.
T2 Biosystems, Inc. has understood the implications of the aforementioned
problem and has focused on the development of the T2Candida®, which is able to
detect five species of the fungal infection candida. Candida is a fungal infection which
may also cause Sepsis. Previous tests took anywhere between two to five days to
return results, whereas the T2Candida® provides a result in approximately 3 hours.
The reduction of time decreases the mortality rate from 40% to 11% as well as the
hospitalization time of patients. The identification of the correct pathogen eliminates
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the need for treating the patient with broad spectrum antibiotics. The potential
savings are estimated to be $4.3 billion only in the U.S: healthcare system [31].
POC devices are therefore suitable to provide results faster than as many other
methods currently on the market. Föllscher et. al. [18] and Gerbers et. al. [19] show
that in case of PBD not only a qualitative results can be measured with these devices
but quantitative results as well.
The goal is to develop a fluidic circuit which makes it able to determine the
concentration of IαIP by conducting ELISA on a paper based platform by measuring
the color intensity on the detection spot. The color is measured using the program
ImageJ®.
1.7

Objective and Outline of the Thesis

The structure of the thesis is as follows:
Chapter 1 – Introduction – gives a brief introduction covering the illness sepsis
and introduces the function and advantages of Point‐of‐Care devices. Furthermore,
two methods to detect IαIP are discussed.
Chapter 2 – Literature Review – discusses the current state of the art. Several
fields of application, production methods of POC devices and a detailed review of
immunoassay test are shown. Furthermore different types of fluid flows are
reviewed.
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Chapter 3 – Methodology – illustrates the experiments which were done during
the thesis. Biological spot test, development of a fluidic circuit and assay
development are found in this chapter.
Chapter 4 – Findings – shows and discusses the results of the experiments
mentioned in chapter 3.
Chapter 5 – Conclusion – summarizes the findings and proposes future directions
of this research.
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2

CHAPTER 2 ‐ REVIEW OF LITERATURE
This chapter is about the state of art in the development of paper based

microfluidic devices. First of all, the elements of a fluidic circuit are discussed and
different techniques to modify the paper surface to make it suitable for biological
reagents are explained. Furthermore, the performed ELISA test is illustrated. Finally,
the fluidic system research is summarized along with different methods to fabricate a
PBD.
2.1

Elements of a fluidic circuit
The most commonly known point of care device is the lateral flow strip;

Pregnancy tests or simple drug test are examples of LFS. In Figure 2‐1 a typical lateral
flow device is displayed.

Figure 2‐1: Typical lateral flow device [32]

A lateral flow test is mostly surrounded by a plastic housing. This housing stores
the complex paper strip. It also prevents the fluid from evaporation and
contamination. Furthermore, applying a sample is facilitated through the sample
port. A cutout in the housing allows users to view the test and control line. When the
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fluid is applied to the sample port it wicks through the sample pad to the wick or
absorbent pad. By flowing down the strip, the sample interacts with the labeled ABs
which were previously dried onto the conjugate pad. The test and control lines are
located on the nitrocellulose membrane. Nitrocellulose paper has a high affinity for
proteins because of the potentials for electrostatic charge. Every time the test is
completed successfully the control line should be visible or change color regardless of
the outcome of the test line. The test line only changes color or becomes visible
when the analyte is present in the sample, otherwise no color should be present [32].
2.1.1 Nitrocellulose
Nitrocellulose is formed by exposing cellulose fibers to nitric acid. It is
commonly used in the antigen‐antibody in pregnancy tests as a detection area. The
detection areas are key functional units in a lateral flow device [33]. The antibodies
usually remain bound to the nitrocellulose through electrostatic binding forces.
These forces act between the nitrocellulose fiber (left) and the protein (right). The
forces are illustrated in Figure 2‐2.

Figure 2‐2: Electrostatic binding on nitrocellulose [33]
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A nitrocellulose fiber is a cellulose fiber with nitrate ester. Nitrogen and
oxygen form strong dipoles which interact with the peptide bonds of the protein.
These electrostatic forces are not influenced by altering the pH‐value.
Fluid runs over the membrane and the analyte which has to be detected e.g.
IαIP binds to the immobilized AB. The correlation between the capillary flow rate and
the sensitivity of the lateral flow test is inversely proportional; meaning the faster
fluid flow over that spot will result in a decreased sensitivity. Furthermore, a strong
signal compared to the background noise is required; otherwise a satisfactory result
may not be determined [33].
2.1.2 Conjugate Pad
The conjugate pad is a storage area for the detection antibodies, which are
labeled with colored nanoparticles or an enzyme like alkaline phosphatase or
horseradish peroxidase (HRP). An ELISA test uses detection AB. These ABs are usually
dried onto this pad and are released during interaction with the sample. The sample
solution contains the analyte e.g. an antigen which binds to the labeled AB. An
immuno‐complex of analyte and AB is formed. According to Healthcare [33] an ideal
conjugate pad has to fulfill the following attributes:
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(1) Low non‐specific binding
The dried detection reagent has to be re‐mobilized easily when the
sample runs over the pad. If it cannot be re‐mobilized, there will be no
immunocomplex at the test line.
(2) consistent flow characteristics,
The reagent needs to be solubilized steadily to have a uniform signal
development. Streaks on the membrane are indications of a non‐uniform
flow.
(3) consistent bed volume
The amount of detection fluid which is loaded in sample the pad needs to
be the same every time the test is performed, if quantitative results are
desired.
(4) low extractables
There must not be any other particles which might bind to the analyte or
the detection antibodies.
(5) Good web handling characteristics and consistent compressibility
These two characteristics facilitate high yield manufacturing and ensure
an overall good connection between and the various membranes.
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2.1.3 Absorbent Pad
The absorbent pad is important to ensure a sufficient and continuous flow. It needs
to have a sufficient size with a big absorption volume to ensure a continuous capillary
fluid flow.
2.2

Biology Research
As discussed earlier the PBD’s consist mostly of paper. The involvement of

dipolar forces in paper can cause problems regarding biological reaction. The goal is
to minimize unwanted interactions which affect biological processes on the chip. The
following abstract presents ways how the reagent paper interactions can be
minimized.
2.2.1 Paper Surface Treatment
Paper provides certain advantages in comparison to the 96‐well plates which
are commonly used for ELISA. On the one hand ELISA can be conducted on paper in
less than an hour with far less fluid (for example 20μl). The incubation time is shorter
compared to plastic wells because the surface to volume ratio is much higher, which
allows the reaction to take place faster. The overall time can be reduced to a couple
of minutes. With the help of certain color enhancer, the result is readable by eye or
can be evaluated using a desktop scanner. No expensive plate reader is needed. On
the other side, the reaction conducted on paper is opened to the air which makes the
result highly dependent on temperature and humidity. These are reasons why the
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LOD of PBD’s is not as low as with 96‐well plates. Nowadays, the order of magnitude
with respect to LOD is three times higher than with 96‐well plates [34].
The use of a paper‐based materials changes the way an ELISA test is
conducted. This change is challenging because paper has a different surface structure
than that of a well in a microtiter plate. Many reagents are used in the area of
biological testing, like proteins and enzymes [35]. In general when paper is used its
surface needs to be modified in a certain way to counteract certain effects which can
influence biological processes. Proteins interact with paper fibers due to e.g. Van‐
der‐Waals forces and the resulting dipole moments. Consequentially, non‐specific
binding can occur [33].
It is very important to minimize these interactions on the nitrocellulose to
obtain a high quality result in the form of a clearly visible concentrated spot. Many
groups have been researching methods to minimize non‐specific binding. So far the
approaches fit into two main strategies: surface modification or adsorption of a
secondary protein [36].
The first strategy is to graft the surface or adsorb hydrophilic molecules on
possible binding areas. The modified surface interacts only weakly with the detection
antibodies [37]. The other method is to treat the paper with a secondary protein e.g.
bovine serum albumin (BSA). This step prevents the non‐specific binding of proteins
to areas other than the already immobilized proteins [38]. One explanation is that
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BSA blocks vacant binding sites on the nitrocellulose membrane so that antigens and
antibodies can be react more uniformly so that more “sandwiches” are formed [39].
A third approach is to treat the paper with amino (NH3) and carboxyl (COOH)
altered silicon dioxide (SiO2). Figure 2‐3 shows the influence of NH3, and COOH‐SiO2
blocking.

Figure 2‐3: Effect of SiO2 blocking [40]

With the antibody concentration is increased, the mean intensity increases
because more sandwich structures are formed. The signal on the SiO2 treated paper
is seven times higher than on untreated paper, whereas the effect of NH3‐SiO2 is
higher than the COOH‐SiO2. With increasing concentration of ABs the mean intensity
variation vanishes between treated or untreated paper. However, the concentrations
should always be kept as low as possible to increase the LOD later on.
Wang et. al. [41] reports on a chemiluminescence ELISA (CL‐ELISA) on
Chitosan modified paper. Using Chitosan wet‐strength and the ability to bind
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antibodies onto paper is improved. Chitosan and cellulose are structurally closely
related and therefore more compatible [42]. Furthermore the mechanical strength is
improved [43]. Wet‐strength means that when the material gets wet it maintains its
shape whereas mechanical strength might be affected by chemical reagents which
make it brittle. In chemiluminescence reactions visible or ultraviolet light is emitted
during the chemical reaction. Larsson et. al. [36] shows that viruses (M13
bacteriophage) can be detected on paper. To adsorb viruses electrostatically onto
paper polyelectrolyte multilayers (PEM) are used in combination with anionic poly‐
acrylic acid (PAA) and cationic poly‐allylamine hydrochloride (PAH).
2.2.2 Signal Enhancement
ELISA tests are commonly performed using a 96‐well microtiter plates. The
bottom surface is coated with a protein or antibody. Afterwards reagents are added
and incubated at a certain temperature. Finally the plate is inserted into a microplate
reader and illuminated with appropriate wavelength light. The reflected light is then
measured. The wavelength indicates which kind of light is absorbed and the intensity
of the color spot correlates to the concentration of the target substance.
Experiments conducted in microtiter plates have been expanded for use on
paper‐based devices. ELISA on paper was first conducted by a group from Harvard
University, Cheng et. al. [34]. In general POC must not rely on expensive equipment.
Therefore, a visible, readable detection scheme that does not rely on expensive
equipment is most preferred. At the least, this may come in the form of a color
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gradient to evaluate different concentrations. So far the limit‐of‐detection (LOD) for
Rabbit IgG, for examples, is about 5 ng/mL which is demonstrated by Gerbers et. al.
[19] and Föllscher et. al. [18]. There is still a difference of one to two orders of
magnitude between paper and microtiter plate. At the very low levels of
concentration, the color spot on the detection membrane cannot be read with the
naked eye. In the following section, the use of color enhancer and rinse steps are
illustrated
Evaluation methods performed by Chaaban et. al. [12] do not need an
amplified signal because variations in the wavelength of a couple nanometers can
easily be observed using a 96‐well plate reader. But the use of signal amplification
and rinse steps are necessary to develop a Point‐of‐Care device from which results
can be evaluated without any extra instrumentation.
Fu et. al. [44] searches for new method to enhance the color signal on the
detection spot. She proposes a rinse step and a chemical amplification step to get a
stronger and clearer signal. A rinse step is needed to remove unbound proteins,
which could interfere with the results. If these unbound proteins are not removed,
the substrate will have more opportunities to bind to an AB and will result in an
unclear color spot is slightly all over the detection area. The rinse step washes all
unbound antibodies away to which a colored AB can bind which reduce the area
where a color change is induced and the signal is more concentrated on one spot.
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Another opportunity to strengthen the signal is the use of color particles. The
enhancement of a detection spot with gold particles is adapted by [45] . In Figure 2‐4
the influence of an amplification step is illustrated and in Figure 2‐5 the signal
strength is plotted over the analyte concentration with and without a rinse step.

Figure 2‐4: Signal amplification using gold
particles [44]

Figure 2‐5: Effect of a rinse and amplification
step [44]

The sandwich structure of analyte and antibodies illustrate how the signal is
amplified. Below it can be seen that the gold enhancement facilitates the visual
detection whether there is a positive reaction or not. The signal of the spot which is
not washed and amplified with gold particles has a lower signal than the rinsed and
amplified spot. The magnitude of the signal with a rinse step is up to four times
higher than without a rinse [44].
An alternative method to enhance the colored spot onto the detection area is
performed by Murdock et. al. [20]. They use different substrates in their ELISA‐test in
order to detect less concentrations of NYP. The use of different substrates which
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induce a color change at the AP‐labeled detection antibodies is varied. In Figure 2‐6
the difference between two different substrates is illustrated.

Figure 2‐6: Rabbit IgG detection using BCIP/NBT (left) pNPP (right) [20]

The Red‐Green‐Blue (RGB) intensity is plotted over the concentration of
Rabbit IgG. It can be seen that the LOD for the pNPP is much lower than that of
BCIP/NBT. Murdock et. al refer to the fact that the alteration of BCIP/NBT is a two‐
step process where BCIP is immediately hydrolyzed by AP. Then it transforms NBT to
the final product NBT−formazan indigo colored dye final whereas pNPP is directly
hydrolyzed to form the yellow end‐product, p‐nitrophenol. The paper matrix might
cause problems regarding the diffusion of the formed NBT‐formazan. Another
explanation is that AP creates different rates of hydrolysis using different substrates
which increase the intensity of the detection spot.
2.2.3 ELISA‐Test to determine IαIPs
The ELISA‐test to determine the concentration of IαIP uses antibodies, which
only bind to IαIP, and a subsequent color generation by induced by the use of
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horseradish peroxidase (HRP) enzyme and the 3,3'‐diaminobenzidine (DAB)
substrate. The color spot’s intensity, in relation to the background on the
nitrocellulose membrane, corresponds to the concentration IαIP within the sample.
In Figure 2‐7 the schematic of the ELISA test is illustrated.

Figure 2‐7: ELISA for detecting IαIP

The first step is to immobilize monoclonal antibodies 69.31 (MAb 69.31) on
the nitrocellulose membrane. Afterwards the detection area is blocked. This can be
done with Superblocker (Föllscher et. al. [18] and Gerbers et. al. [19]) or with non‐fat
milk powder diluted in PBS Lim et. al. [14]. Then the sample containing a certain
concentration of IαIP flows down the main channel and binds to the biotin labeled
polyclonal detection antibodies R21, which are dried in the conjugate pad. The
IαIP/R21 conjugate then flows over the test spot where the IαIP portion of this
conjugate is captured by the immobilized monoclonal antibody 69.31 at the test spot.
A portion of the sample fluid, through a different channel, triggers the flow of the
solution containing HRP enzymes tagged with streptavidin and which is stored at one
of the reagent pads. This solution flows over the test spot and the HRP enzymes are
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captured by the immobilized R21 antibodies via the streptavidin/biotin bond. Yet
another portion of the sample fluid via a different channel triggers the flow of the
DAB substrate which is stored in another of the reagent input pads. This solution
containing the DAB substrate then flows over the test spot where it reacts with the
immobilized HRP enzymes and produces a brown colored product that precipitates at
or near the test spot, thus making it visible. By measuring the darkness or color
intensity of this spot for various known IIP concentrations in the sample, a
calibration or standard curve or a color chart can be produced so that the
concentration of IIP can be inferred in samples where the concentration is
unknown.
2.3

Fluidic Research
Besides the biological reaction on the chip the fluidic system which is necessary

for the success of the enzymatic or enzyme linked test has to work properly and
reliable in every environmental condition. This chapter illustrates the state of art and
shows different approaches how to influence the fluid flow.
2.3.1 Channel geometry
Designing a fluidic paper chip is a long procedure because of the large number
of variables that one has to be aware of during the procedure. For this reason,
calculations have to be made to predict the flow characteristics to avoid additional
testing after fabrication. In general there are two equations which can be used to
estimate the capillary fluid flow, the Washburn equation and Darcy’s law. Equation
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(1) is the Washburn equation. It is used to calculate the time for a fluid to flow on
and in a dry porous material of a certain length L over a time t.

(1)

4
The time t is directly dependent on length L, the surface tension γ, the dynamic
viscosity η and the pore diameter D. The experiments are performed at room
temperature (25 degrees C). The surface tension γ of water is estimated to 0.0728
and the dynamic viscosity η is about 1.002 ∗ 10

[46]. Darcy’s law also describes

fluid flow but it is used when the fluid flows on and in materials which have been
already wetted.

(2)

μ

μ

Q is the volumetric flow rate, A is the area of the channel which is
perpendicular to the flow, κ is the permeability of the paper, μ is the viscosity of the
fluid, ΔP is the total pressure drop along the travelled path and L is the length of the
channel. The value for ΔP at room temperature is 4,560

[47]. Rearranging Equation

(2) with respect to the time provides Equation (3).

²

(3)

Where V is the Volume transported with a flow Q over time t. Regarding these
two equations the flow of a fluid depends on geometrical variables such as length or

29

width of a channel as well as the atmosphere parameters within which the paper
and the fluid are used.
2.3.2 Expansion and contraction
Fu et. al. [21] has conducted studies about how the width of the channels
affects the fluid flow. Therefore, paper strips with different widths and different
combinations of contraction or expansion were studied.
In Figure 2‐8 the effect of an expansion on the movement of the wave front is
pictured. Channels A‐E have different geometries, whereas Channel A‐C are similar
except for the beginning of the expansion. The other two channels are different with
respect to their widths.

Figure 2‐8: Effect of an Expansion [21]

The diagram on the right illustrates the distance in mm over the square root
of time, √t . It can be seen that the distance travelled in design A‐C decreases
depending on the location of the expansion. The reason for this is that the smaller
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width channel restricts the amount of fluid that may travel beyond. The fluid slows
down but in design D and E the velocity is maintained. According to equation (3) the
velocity of the fluid flow is the same when the width is constant irrespective of how
wide the strip is.
The counterpart of an expansion of width is a contraction. Fu et. al. [21] set
up the same strips but a strip design is inverted. The experiment is pictured in Figure
2‐9.

Figure 2‐9: Effect of a Contraction [21]

Again the distance is plotted over the square root of time. In comparison to
the expansion there, is rather no difference between the channels A‐E. The fluid is
not restricted by the wider part of the channel as it provides an unlimited source of
fluid. These experiments show that the flow of a fluid can be slowed by including a
narrower channel.
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2.3.3 Reagents storage
Enzymatic reagents are stored in dry form to be released later when fluid runs
over that area. Typically, proteins are dried on the conjugate pad. To facilitate the
protein re‐mobilization, mixtures of trehalose, sucrose and BSA are used. Otherwise,
it is not possible to redissolve the proteins again after they are dried onto the pad.
The use of sugar provides not only a better release of pre‐dried proteins but can also
delay the flow of fluids. Fridley et. al. [24] uses sugar as a barrier to slow down fluid
flow. First the focus is on the storage and release of reagents. Figure 2‐10 and Figure
2‐11 illustrate how sugar solutions can facilitate the re‐mobilization of proteins.

Figure 2‐10: Sugar solution facilitates Protein release [24]

Figure 2‐11: Sugar Barriers [24]

Different types of solutions were tested. The detailed composition of the
fluids can be obtained from Figure 2‐10. Stevens et. al. [48] discusses how trehalose
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and sucrose molecules substitute for the water hydroxyl groups which are lost after
drying. When fluid runs over the dried proteins hydroxyl group re‐substitute for the
sugar. The release is therefore easier in comparison to the glucose. The left image in
Figure 2‐10 shows that in composition IV no protein remains on the original spot of
immobilization. Furthermore, trehalose has the ability to protect the protein from
physical and chemical damage.
Aside from the release facilitation, sugar can be used to delay the fluid flow.
The right image of Figure 2‐10 shows that the higher the amount of sucrose, it delays
the fluid flow longer. Sucrose barriers are therefore an additional method to control
and delay the fluid flow.
2.3.4 New elements for a Fluidic Circuit
Instead of using geometrical changes to control the flow of the fluid, circuit
components were invented. These components like a switch or a valve provide better
fluidic control. The following summaries provide a better understanding of the
manually activated mechanical switch, developed by Martinez et. al. [49] and the
autonomous fluid actuated valve technology developed by Chen et al. [49].
2.3.4.1 Mechanical Switch
Martinez et. al. [49] developed microfluidic paper‐based analytical devices
(µPADs). They introduced a mechanical switch which is illustrated in Figure 2‐12. The
switch consists of multiple layers of wax‐treated paper channels which are adhered
with layers of tape. The hydrophilic inlets vertically match with the counterpart, but
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the space in between these two layers has no material to bridge the fluid flow,
leaving an air gap. This gap can be manually manipulated as soon as the fluid reaches
the switch to continue the flow, in essence, by eliminating the air gap. The use of a
switch further extends the possibilities for fluid flow control. Using multiple switches
in one device can allow for the inclusion of multiple assays. The fluid can therefore be
deliverable when needed through a physical manipulation of the switch.

Figure 2‐12: Mechanical Switch and examples of application [49]

The major disadvantage of this method is that user interaction is necessary. A
trained person still has to activate every switch. The person who has to work with
these devices needs to have basic knowledge of the procedure. This, however, is not
the intention of the field of POC‐devices. Little to no interaction is preferred and that
rules out the potential for incorporating a mechanical switch.
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2.3.4.2 Fluidic Valve
A new technology, which acts like a switch but does not require a user
intervention, was developed by Chen et. al. [50]. The valve technology makes it
possible to sequentially load fluids without any action by the user during the
operation of the PBD. The principal of operation of this valve is illustrated in Figure
2‐13.
The fluidic valve is similar to an electric diode (Figure 2‐13a). An electric diode
consists of an anode and a cathode. In this particular case, the current may not pass
from cathode to anode, but the reverse is possible. The direction of the electrical
flow is dictated by this electrical part. In his dissertation, Chen et. al. [50] transfers
this principle onto a paper valve which is able to control fluid flow with the help of
chemically treated components. The anode still represents the conductive part and
the cathode the non‐conductive part.
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Figure 2‐13: Principle of a Fluidic Valve [50]

In a fluidic context, this means one side of the paper‐valve is hydrophobic, to
block fluids, while the other side is hydrophilic, allowing for fluids to pass by. The
hydrophobic side of the valve is treated with Allyltrichlorosilane (A3CS). The
hydrophilic side is not treated with a solution but rather a surfactant which is placed
in between hydrophobic and hydrophilic sides. When it is dissolved in water,
surfactant materials are able to bridge hydrophobic areas (Figure 2‐13b). The valve is
then opened and fluid can flow in both directions whereas an electrical diode always
blocks one direction of the flow.
With this new technology, advanced control of fluid flow is achieved. In Figure
2‐13c the ability of the valve to block fluids is illustrated. On the left side the
surfactant is dissolved and the hydrophobic area is bridged. Finally the colored water
can flow to the end of the channel. On the right side the hydrophobic area cannot be
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bridged due to the lack of dissolved surfactant which breaks down the hydrophobic
area. The fluid is not able to continue its flow.
POC devices must not have a lot of user interaction like applying reagents on
the paper chip in a certain order because these user interactions offer possibilities for
failure. Reagents may be applied on the wrong area, too early, too late or may be
forgotten. Therefore, it is necessary to reduce user interventions as much as possible
to meet the requirements of a POC device [51]. The valve presented by Chen et. al.
[50] is an approach in the right direction to reduce user interaction and make POC‐
devices suitable for more and more fields of application
2.3.4.3 Delay Channel and Sequential Loading
The fluidic paper valve as discussed in section 2.1 is able to stop the flow of a
fluid because when the valve is aligned in a certain way it blocks fluid flow along one
direction. A delay channel is combined with another fluid to reach the valve from the
opposite side. The valve is opened from the delayed channel. The so called “trigger”
fluid opens the valve. Another possibility is that the blocked fluid can open the valve
on its own by flowing along a second path to the surfactant region of the valve. The
principle of a delay channels is illustrated in Figure 2‐14.
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Figure 2‐14: Delay Channel [50]

Lutz et. al. [26] proposed a method to load fluids sequentially with no user
interaction. A chip is designed with channels on which reagents are dried. All
channels have a different length because when the fluid level of the source drops the
connection to the fluid is no longer maintained. The experimental set up and results
are shown in Figure 2‐15.

Figure 2‐15: Sequentially loading of dried reagents [26]

At first all channels are connected to the fluid. Sequentially, the channels
disconnect from the fluid as the source fluid level decreases. The displayed color
trend shows a sequentially loaded fluid. The color of the detection strip changes from
yellow to blue then to to red which demonstrates the principle of sequential loading.
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Fu et. al. [52] run a similar experiment but pH‐paper is used instead of filter paper. In
this case the color change is based on a different pH‐value caused by different
buffers.
Another method is shown by Dr. Hong Chen using a paper valve in combination
with a delay channel. This makes it possible to load fluids sequentially without any
user interaction after loading the chip with fluids. The principle is shown in Figure
2‐16.

Figure 2‐16: Sequentially Loading of a Fluid [50]

Two different fluids (A and B) are applied on the circuit. Fluid B stays on its spot
because it cannot pass the valve. Fluid A can flow only in the right direction because
a valve on the left side blocks its flow. It first opens diode 1 Fluid B, however, cannot
flow to the test spot because diode 2 is still closed. Fluid A along with some of Fluid B
is flowing over the delay channel to the diode 2. This opens this valve and now allows
fluid B to flow in the horizontal direction towards the left and over the test spot. Both
fluids end their flow in the absorption terminal.
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2.3.5 FEM modeling of fluid flow
The production and testing of PBD is time consuming. A way to minimize effort
through fabrication and to improve the yield is to simulate the fluid flow in a finite
element model. Zimmermann et. al. [53] conducted an analytical simulation on the
optimization of sensitivity, sample volume and on the time to complete a test. Their
numerical results coincide with the analytical results which prove that a
mathematical model is valid method for estimating fluid flow. This proves that PBD
can be tested without actually fabricating one. Fu et. al. [54] developed a model
regarding convection, binding and diffusion inside the fluidic channel. With a simple
2D finite element method it is possible to predict assay results when input
parameters vary. By using a computer model, resources can be saved and the
amount of testing can be reduced. Of course, results need to be validated with a
physical model of the PBD but the amount of chips needed to be fabricated is
reduced.
2.4

Fabrication Research

2.4.1 Different fabrication techniques
Paper‐based POC devices may incorporate paper that is treated and
manufactured in many different ways. An overview of several different
manufacturing techniques is summarized in Table 2‐1.
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Table 2‐1: Fabrication Methods an Overview [55]
Fabrication
Method

Photolithography

PDMS plotting
Inkjet printing

Advantages

Drawbacks
Organic solvents

200μm barriers

Less flexibility

Sharp resolution

Expensive and complicated steps

Preserves flexibility

Special treatment of PDMS needed

Patterning directly on

Whole paper has to be treated

paper

Exposure to solvents and polymers
Need additional tape to stabilize

Cutting

Easy to fabricate

structure
Limited geometry

Plasma etching

Patterning directly on

Whole paper has to be treated

paper

Exposure to solvents and polymers

Fast and easy to produce
Wax printing

Preserving native chemistry
Cheap instrumentation

High resolution not possible because
wax spreads out
Careful determination before wax
printing

Paper and toner

Results available as a

High temperature used in lamenting

Laminating

snapshot

process

Very fast to fabricate

contours are not very sharp

Faster than printing

screen stencil needed to fabricate

Wax screen
printing
[41]
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Photolithography is one of the first production methods which involve
hydrophobic and hydrophilic reagents to produce channel geometry. UV light is used
to bake hydrophobic barriers into the paper. This method has a high resolution with
200µm barriers which slow down the fluid flow. Unfortunately, many complicated
steps with organic solvents render the paper less flexible and harder to handle [56].
In the case of PDMS plotting, the hydrophobic layer is created with a desktop plotter
and the hydrophobic polymer Polydimethylsiloxane (PDMS). The chemical treatment
with PDMS preserves the flexibility of the paper when compared to photolithography
[57]. In the case of the inkjet printing, a solvent is directly printed onto desired
regions of a hydrophobic paper. This procedure is good for high mass production
because not many steps are involved. Plasma etching is a similar manufacturing
method which uses a small amount of plasma. A side effect of both methods is the
use of hazardous chemicals and polymers [58]. Cutting filter paper is the simplest
fabrication method. In addition to the filter paper tape or another stiff material
needs to be incorporated to maintain the rigidity of the cut pattern [59].
Nowadays, wax printing is the most common method to manufacture paper‐
based POC. Printing wax on paper is easy and affordable because a standard low cost
wax printer can be used. The resolution is not as good as other processes because by
melting the wax hydrophilic areas shrink and undesired spreading of wax might occur
Carrilho et. al. [60]. For our conditions we found that the line geometries shrink by
about 0.5mm in each direction which need to be considered in the fabrication
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procedure. Another method called wax‐screen printing is presented by [41]. In this
procedure, wax is rubbed through a stencil and melted afterwards into the paper. No
extra gadgets except for an oven are necessary to produce paper chips [41].
2.4.2 From 2D to 3D
The circuits discussed in the previous chapter are only in 2D. POCs, however,
have to be capable of running more complex tests involving multiple fluids.
Producing paper based devices in 3D has a number of benefits [61], [62]. They are:
Smaller chip size; smaller volumes of reagents; and faster assay times. Our new 3D
Delay circuit and the 3D Sequential Loading circuit are shown in Figure 2‐17 and
Figure 2‐18.

Figure 2‐17: Delay Circuit in 3D [50]

Figure 2‐18: Sequential Loading in 3D [50]

43

As illustrated above the valve can be vertically aligned in several layers to
transfer the principal of sequential loading into a 3D format. In Figure 2‐17 the 3D‐
Delay Circuit is shown. It consists of two layer of paper connected by a layer of
double sided tape. In the tape, in both figures, are made holes. One is filled with a
hydrophilic disc, which essentially forms a fluidic short between the top and bottom
layers of paper. The other holes are each filled with a hydrophobic disc. In the
bottom layer and aligned with the hydrophobic discs is deposited surfactant to
complete the fluidic diode or valve. Figure 2‐18 demonstrates sequentially loading of
two fluids past the test spot. To be completed the 3D delay circuit requires two more
layers. One is a thick absorbent paper sheet and a second layer of double sided tape
to attaché this sheet to the whole device. The thick paper layer serves to ensure a
sufficient capillary flow rate. The completed chip now consists of five layers. The
capillary flow action of the 2D format works in just the same methods. In total two
fluids are applied on the chip (A and B). Fluid B stays above the hydrophobic disc
unable to flow any further until Fluid A flows to the second layer and dissolves the
surfactant underneath bridging the gap to fluid B. This chip shows that it is possible
to sequentially load multiple fluids using the developed 3D paper circuit without any
user interaction [50]. Additional control of the fluid flow can be achieved by designed
delay channels with a different length, width or porosity [61].
Since the fabrication process takes a lot of time, Lewis et. al. [62] proposes a
high throughput method for fabricating paper‐based microfluidic chips. Instead of
44

putting double sided tape in between two layers spray adhesive is used. Spraying
adhesive in between two layers the number of layers in one chip can be reduced. In
total this means 40% less paper and 50% less time to complete a test. Furthermore,
the tedious assembly steps, which affect the reproducibility of the chips, are
eliminated. By reducing the number of layers the time needed for a fluid to travel
through all layers is reduced. According to Lewis et. al. [62] interactions of the
adhesive with reagents used in the chip, which might influence the quality of the
results or alter the wicking rate of the paper, were not observed.
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3

CHAPTER 3 ‐ METHODOLOGY
This chapter describes the fabrication processes for a paper based microfluidics

chip for the detection of IαIP, a biomarker for sepsis. Several optimization steps and
the assay protocol are also discussed.
3.1

Chip Fabrication
All paper chips are fabricated according to the fabrication methods which were

previously introduced by Wilke Föllscher and Roman Gerbers. Six identical chips are
fabricated at once in a single batch. A basic chip consists of at least three layers and
blotting paper at the bottom to absorb fluids. Two layers of filter paper are printed
with wax printed fluidic channels and a layer of double sided tape holds the layers
together. The connection of the two layers is satisfied by spreading hydrophilic
material in the holes of the tape layer. To form a more complex chip which can
handle more than two fluids, additional layers with wax printed fluid channels are
necessary.
3.1.1 Different types of paper
Fluids can only flow in the hydrophilic areas of the paper. To control the fluid
flow, wax patterns are printed onto the filter paper. The black areas with wax form
hydrophobic areas and white blank areas are hydrophilic. In these the fluids may
flow. The black and white printing patterns are created using software Corel Draw®
(Corel®). The channels are printed on a 8x10 inches filter paper (Grade 41, 20 µm)
from Whatman® using a solid ink printer (Xerox® ColorQube® 8570) with solid ink
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(Xerox® Genuine Solid Ink Black). Afterwards, the paper is cut with a CO2 laser cutter
(Epilog® Mini 24) to maintain accuracy and proper alignment during assembly. The
printed wax channels are only printed on one side of the paper but the black
hydrophobic wax areas have to be melted all the way through the paper to prevent
the fluid flow in undesired regions. Therefore the printed filter paper is placed with
the blank side up in a vacuum oven (Isotemp® Model 280A, Fisher Scientific) for 30s‐
40s with a temperature 130°C‐140°C. The wax is allowed to melt through the entirety
of the filter paper leaving a blank printed pattern which carries through to the
opposite side of the paper. Depending on where the paper components are placed
within the oven, the melting time can vary due to the varying temperature gradient,
which makes it necessary to place the chips in the middle of the oven. Figure 3‐1
shows what wax‐treated and untreated paper looks like.

Figure 3‐1: Wax on Paper [61]
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Paper treated with wax is more compressed than paper without a wax
treatment. The wax coating prevents liquids from traveling in undesired areas on the
paper because it fills in the pores thus forming solid hydrophobic walls. In addition to
filter paper two other types of paper are used, which are the blotting paper and an
absorbent paper. These types of paper are used to maintain a steady fluid flow
throughout the chip. Gel blot paper (GB003) from Whatman® and glass fiber
membrane filters (GA‐55) from Sterlitech® were purchased. The blotting paper forms
the foundation of the chip providing a rigid support.
3.1.2 Double Sided Tape
The tape layer in another important component, it is used to hold adjacent
layers of filter paper together. Double sided tape from Ace Hardware (Item No.
50106) is taped onto wax paper for handling and cutting purposes (Parchment Paper,
Reynolds®). Later on the top coating of the tape and the parchment paper are
removed leaving only the two adhesive sides. In total, three different types of double
sided tape are cut. The tape between first and second layer has holes cut out, also
cutouts for the absorption pads and small strip cutouts for the nitrocellulose filter
and detection areas are included. These cutouts are helpful to align the small filter
and detection spots on the tape. The second type of tape is similar to the first tape
layer except of the cutout stripes because there are no filters etc. which need to be
aligned properly. The last layer has only cutouts for the absorption squares. The
cutting patterns are designed in Corel Draw® as well and cut with the CO2 laser. The
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aforementioned holes in the tape are cut with the CO2 laser. The settings of the Laser
cutter vary depending on what will be cut. A summary of all laser settings is displayed
in Table 3‐1.
Table 3‐1: Printer Settings
Material
Laser Power
Backing Paper
40 %
Double‐sided
40 %
tape
Filter paper
40 %
Glass fiber
(absorption
40 %
area)
Glass fiber
(conjugate
40 %
pads)
Nitrocellulose
40 %
Plastic PP‐
40 %
Layer 1.5mm

Vector Speed
40 %

Vector Power
17 %

Frequency
5000

50 %

25 %

5000

55 %

15 %

5000

45 %

13 %

5000

85 %

7%

3025

40 %

2%

4250

10 %

30 %

5000

3.1.3 Hydrophobic Layer and Surfactant/Hydrophilic Paste
The hydrophobic layer has the most important role in the fabrication of an
autonomous immunoassay circuit, after the surfactant paste. It ensures that certain
fluids cannot pass through a specific way unless a trigger fluid bridges the
hydrophobic area of the paper. This is the principle of a delay channel introduced in
section 2.3.4.3. Therefore, the surfactant enriched paste, which is placed and dried
underneath the valve, needs to be dissolved in order to open the valve and release
the stored fluid.
To create a hydrophobic disc, the 3mm wide spots have to be treated as
specified by Föllscher et. al. [18] and Gerbers et. al. [19]. 8µl of the hydrophobic
solution has to be pipetted but in 4x2µl drops on one spot otherwise the solution
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evaporates too fast and cannot soak into the paper. The hydrophobic layer is
illustrated in Figure 3‐2 where only the four bottom spots in the center of the
drawing are treated with the hydrophobic solution.

Figure 3‐2: Hydrophobic Layer

The hydrophobic solution is a mixture of 4.76 Vol.‐% Allyltrichlorosilane (ALS) in
Perfluro‐compound (FC‐72). After the treatment the sheets of the paper have to be
stored in a covered petri‐dish overnight to fully develop their hydrophobic
characteristics.
The surfactant paste is placed in the other side of the hydrophobic paper.
Together they form the paper based valve. The surfactant solution is a 35 wt.%
dilution of Tween 20 in Ethanol. The next step is to dilute 0.25mL/mL surfactant
solution in ultra‐pure water. The final step is to mix the water‐ethanol‐surfactant
solution with the cellulose powder (0.5 g/mL). Holes without a hydrophobic spot are
filled with hydrophilic paste to bridge the layers of filter paper. The hydrophilic paste
is a mixture of cellulose powder in ultra‐pure water (0.5 g/mL).
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In addition to the different types of paste in combination with a hydrophobic
layer paper, discs are used to build up a valve. In total there are three paper discs
(hydrophobic, hydrophilic and surfactant). One hydrophobic and one surfactant disc
are placed on the tape whereas the hydrophobic disc overlaps the hole to block it.
Unfortunately, after treating paper with hydrophobic solution it becomes brittle, so
many of the discs may crack when they are placed over the hole. This may cause
premature release of the fluid.
3.2

Chip Fabrication
As mentioned before, the chip consists of three single wax paper layers which

are attached to each other with double sided tape. Our paper chip is a hybrid of
Roman Gerbers and Wilke Föllscher design. Föllscher’s design is chosen because the
fluid storage area is much bigger compared to Gerber’s design. A higher amount of
fluid can be stored without the help of wells made out of a 1.5mm thick
Polypropylene plate. The second layer is chosen from Gerbers because in Föllscher’s
design the opening channels are not connected which means that they can be
triggered independently from another. In Figure 3‐3 the selection of layers is
displayed. The first layer is from Wilke Föllscher and the second layer is from Roman
Gerbers whereas the hydrophobic layer is used in both their designs.
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Figure 3‐3: Different Layers of the Microfluidic Chip (First Layer, Hydrophobic Layer, Second Layer)

The use of the alignment tool is necessary to ensure perfect alignment
between each layer of the chip. The first step is to place the blotting paper onto the
alignment tool and attach double sided tape. The double sided tape without any
cutout for holes is used. After the tape is properly aligned on the blotting paper, the
other side of the double sided tape is peeled off. Before attaching the second layer of
the tape the absorbent pads need to be placed in the quadratic cutouts of the double
sided tape, which connect every layer to the blotting paper at the bottom of the chip.
Now the second layer is attached to the double sided tape followed by another layer
of tape. This time the tape with cutouts for paste but without the alignment stripes
for the nitrocellulose and the conjugate pad is needed. Before placing the absorbent
pads the holes in the tape need to be filled with paste, a small metal spatula may be
used. The mixture of hydrophilic and surfactant paste is discussed in section 3.1.3.
The bottom four holes are spread out using surfactant paste because the holes are
under the hydrophobic treated spots. The top hole is filled with hydrophilic paste.
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After spreading the paste the assembled part of the chip, it needs to dry for around
20 min. Meanwhile the conjugate pad and the nitrocellulose membrane may be
placed onto the remaining tape layer which includes cutouts for the holes and the
alignment stripes. Attach the first layer onto this tape layer. Now all holes of the tape
layer need to be filled with hydrophilic paste and subsequently need to dry for 20
min. After that time, the absorbent pads are put into the tape layer and the
hydrophobic layer is attached. The next step is to combine the second layer with the
top layer which includes first and hydrophobic layer. Finally clear tape is put on the
first layer. To be able to place a certain amount of fluid volume onto the chip
Polypropylene (PP)‐wells are placed on the chip. After the assembly is completed the
chip needs to be constrained to ensure sufficient contact at all connection points in
the chip. A summary of all materials (Figure 3‐4) needed and a more detailed
assembly is illustrated in the photographic sequence.
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Figure 3‐4: Materials for One Chip

As previously discussed in section 2.3.4.3, fluids which are used in the fluidic
circuit need to be triggered in the correct sequence. Therefore all length and
positions of the delay channels and amount of fluids have to be adapted for desired
sequential loading. Figure 3‐5 displays how the sequential loading works
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Figure 3‐5: Fluid Flow in the PBD by [19]

There are three fluids which can be applied to the device. In the case of
Gerbers et. al. [19] these fluids are a Sample‐, Substrate‐, and a Wash‐fluid. The
sample runs down the main channel over the conjugate pad and the nitrocellulose
membrane. The conjugate pad stores dried detection reagents which are dissolved
by the sample‐fluid. Meanwhile, the fluid flow was divided into two streams with one
traveling along a second layer. The second stream triggers the valves by dissolving
the surfactant. Then the wash flow removes any unbound capture antibodies from
the nitrocellulose membrane. Finally, the substrate runs down to the waste pad. If
there are the desired antigens present in the sample, the indicator antibodies will
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bind to the antigen‐antibody complex to create a sandwich structure. This structure
becomes visible when the substrate changes the color of the enzyme. A colored dot
can be found on the nitrocellulose which would then indicate the presence of an
antigen.
Our chip has IαIP in buffer as Sample; the second fluid is HRP in buffer which is
not the wash fluid but rather the enzyme. This enzyme attaches to the detection
antibody. In the end the substrate (DAB) introduces a brown color.
3.3

Influence of viscosity of the opening times
The first experiments are conducted with water and food coloring as a proof of

concept for the lateral flow chip and to show that the sequential loading is possible
using the valve technology of Dr. Hong Chen. Later on, IαIP diluted in buffer shall be
used as reagent. The reagents have a different viscosity than water. Therefore the
influence of viscosity has to be evaluated to determine its effects on the time
required to open a valve. With water the time for water to dissolve the surfactant
and open the valve is less than a minute.
Therefore a test with two test chips is developed with 108 valves in total. Six
different concentrations of blood‐plasma in TBS‐buffer are tested: 100 vol.‐% plasma
with no buffer and different dilutions (75%/ 50%/ 25%/ 10%/ 1%‐plasma in buffer).
Each concentration is tested by pipetting 4μl drops on the surfactant side of the
valve. In total, 18 spots per concentration are tested. The dissolve time of the
surfactant to bridge the hydrophobic area is measured. To facilitate the time
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measurement food color is mixed with the fluid because the plasma itself is clear
which making it hard to determine the exact moment when the fluid bridges the
valve. The time is recorded when moment when a colored spot is noticeable by eye
coming through the paper valve.
3.4

Assay Development
To run a complete ELISA it is necessary to optimize all parameters of the

biological assay (Reagent concentrations, amount of fluids needed for the enzymatic
reaction etc.). Therefore it is helpful to split up the complete ELISA to concentrate
on individual parts. After obtaining the desired results one can recombine them to
perform the complete ELISA with each individual optimized component.
Furthermore, this procedure helps to recognize in which part of the experiment an
error occurs. In the following sections the split parts of the ELISA are illustrated.
First, a simple vertical test is performed using two different pairs of reagents
which are both suitable to detect IαIP later on. One reactive pair is BAPNA and
trypsin and the other reaction is conducted using HRP and DAB. The first reaction
results with a yellow color spot and the second reaction results in a brown colored
spot following the enzymatic reaction. Both reactions are evaluated if they are
suitable for further experiments.

57

3.4.1 ELISA Pre‐Testing
As explained earlier, IαIP should connect to the immobilized trypsin. Before a
complete ELISA is conducted, trypsin and BAPNA are mixed in a small vial to confirm
the expected color change from clear to a light yellow.
To produce the trypsin solution, 0.01g trypsin needs to be mixed according to
the SOP from ProThera Biologics© with 50µl of 1M hydrochloric acid (HCl) in 50mL
ultra‐pure water. The HCl is needed otherwise trypsin would digest itself. 0.021g
BAPNA powder is mixed with 1mL Dimethylsulfoxide (DMSO). These reagents are
stored in Triethanolamine‐buffer (TEA‐buffer) at a pH‐value of 7.8. The TEA‐buffer is
produced by putting 3.714g TEA‐powder into 90mL deionized distilled water (dH2O).
Afterwards, small amounts of Sodium hydroxide bring the pH‐value to 7.8. Add dH2O
until 100mL of solution is produced.
Afterwards, the possibility to immobilize trypsin on nitrocellulose and blotting
paper is tested and compared to results that were previously conducted in 96‐well
plate. Different amounts of trypsin (1µl/1.5µl/2µl) are pipetted on nitrocellulose and
(10 µl/15 µl/20 µl) on the blotting paper. The amounts of fluid are chosen regarding
the absorption capacity of the paper. To see whether the trypsin immobilization is
successful the same amount of BAPNA is pipetted on the paper to induce a color
change. When a yellow color shows up the immobilization of trypsin is successful.
The vertical enzymatic test is illustrated in Figure 3‐6.
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Figure 3‐6: Vertical Test Trypsin and BAPNA

Besides nitrocellulose and blotting paper Glass Fiber Membrane Filters are
tested to determine how well they immobilize trypsin. Two different types of
Membrane Filters are tested: One Glass Fiber Membrane filter is treated with a
binder and another is not treated with binder. Varying amounts of trypsin from 2µl‐
10µl in 2µl steps are pipetted onto the filter. Afterwards the color change is induced
using a constant volume of BAPNA (12µl). The experiment is illustrated in Figure 3‐7.
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Figure 3‐7: Vertical Test on Glass Fiber with and without binder

3.4.2 Vertical Test DAB
The different substrate DAB is used for further experiments. Trypsin and
BAPNA which produce a yellow color change are replaced by 3,3'‐Diaminobenzidine
(DAB) and Horseradish peroxidase (HRP). DAB and HRP together produce a brown
color at the place the reaction takes place. Since Murdock et. al. [20], Peng et. al. [40]
and many more use a vertical test for their ELISA. To make sure that DAB and HRP
like trypsin and BAPNA work together on paper further testing needs to be done.
Therefore a 96‐wax‐well plate can be printed onto paper using a wax printer
(Xerox® ColorQube® 8570) and Whatman® Filter Paper 41. The Streptavidin Poly‐HRP
is purchased from Pierce Antibody (Cat. No. 21140) as well as the DAB Powder (Cat.
No. 34001).
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To produce a liquid DAB substrate from powder, instructions from IHC World
[63] are used. The substrate solution has two components with a DAB part and a
H2O2 part. For the DAB part (1% DAB (20x) in Distilled Water) 0.1g DAB are mixed
with 10mL distilled water. Afterwards add 250µl of 10N HCl. The solution should turn
light brown/dark purple.
The H2O2 (0.3% H2O2 (20x) in distilled water) is produced by mixing 100µl H2O2
in 10mL distilled water. Both solutions should be aliquot into small vial and stored at
‐20°C when they are not used. Finally, the substrate is produced by putting 250µl of
both reagents in 5mL PBS X1.
The Streptavidin Poly‐HRP is used in three concentrations (1:3000, 1:6000,
1:8000). Therefore pipette 0.75/1/2µl of Streptavidin Poly‐HRP into 6mL of PBS X1.
The vertical test is performed on blotting Paper with HRP and DAB according to
Figure 3‐8.

Figure 3‐8: Vertical Spot Test DAB and HRP

In total, there are five test spots with varying amounts of HRP and DAB. The
first three spots have an increasing amount of both reagents applied on the blotting
paper. The fourth spot is a reference spot where only DAB is used to see if the color
is different to a test spot with both reagents. This is done to prove that an enzymatic
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reaction changed the color, rather than the substrate which gets darker itself as time
elapses. The spot without no reagents serves as a reference with which the color
intensity of the other spots may be compared. The program which is used to measure
the color spots is ImageJ.
3.5

Enzymatic Lateral Flow Test
The results in section 4.3 show that the use of HRP and DAB is more promising

because of the more intense color on the white background. The next step in the
procedure is to develop a complete ELISA to detect IαIPs which means to transfer the
vertical enzymatic test to a lateral flow test.
Vertical tests often need higher concentrations of all reagents; this test was
developed by Elain Fu et al. They offer the possibility to Lower concentrations to
measure the target analyte.
Therefore a lateral flow test, where 0.6 µl HRP with concentrations of
1/5/10/20/40 μg/mL are immobilized onto nitrocellulose with the pore size of 1.2
μm, is performed. Afterwards 70 μl of the DAB run over the nitrocellulose to create a
color change due to the enzymatic reaction. To reduce non‐specific binding the
channels and the nitrocellulose are blocked with a non‐fat milk solution.
After immobilizing HRP onto nitrocellulose the next step is to use the detection
AB R21 labeled with biotin instead of HRP. The R21 with biotin is supposed to
produce a darker brown color as compared to that of HRP with DAB because of the
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amplification action of biotin. As a result, the spot on the nitrocellulose should be
darker than the background color.
The next section is concerned with optimizing the concentration of HRP and
R21 to receive the best Signal/Background Noise ratio in order to optimize the
opportunity to read the signal.
3.6

Optimization of Detection Antibody and HRP
The following section is split into two parts with each part focusing on the

optimization of R21 in combination with HRP. In the first section R21 is immobilized
onto the nitrocellulose membrane whereas in the second part the detection antibody
is attached to the IαIP forming an ELISA sandwich. Both methods need a separate
view regarding the optimization of the concentration.
3.6.1 Directly Immobilized R21
The upper part of the ELISA‐sandwich consists of the detection AB R21 labeled
with the enzyme biotin. The HRP includes a streptavidin component which is can
attach to the HRP. When the HRP is connected to the R21 with the help of the
streptavidin component, the DAB induces a color change at the HRP molecule. The
problem is to find the optimal concentrations of R21 and HRP. The more R21 on the
nitrocellulose the darker the color becomes and consequently the spot becomes
more blurred with more HRP.
The top part of the ELISA‐sandwich consisting of R21/HRP/DAB is simulated in a
lateral flow test. Different dilutions of 0.6μl R21 in PBSx1 (5/10/25/50/100%) are
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immobilized onto the nitrocellulose with the same procedure as in section 3.5. In
addition to varying dilutions of R21 40μ HRP is used in five different concentrations
(40/20/10/5/1 μg/mL). Since the procedure to fabricate the DAB substrate is fixed to
certain concentrations, a constant volume of 40μl is pipetted onto each spot.
The exact concentration combinations are displayed in Table 3‐2. Each test chip
has a set of five dilutions of R21 and one concentrations of HRP.
Table 3‐2: R21 and HRP tested concentration
HRP Concentration [μg/mL] Dilution of R21 [%]
40
20
10
100/50/25/10/1
5
1
0 (Negative Control)

Afterwards the intensity of the color spot is measured where R21 is
immobilized and divided by the color intensity of the nitrocellulose’s background.
The intensity of the R21 spot is lower because the spot is darker and the background
is usually lighter which means a higher intensity. Therefore the lower the result the
better the signal to noise ratio, this follows vice versa.
3.6.2 R21 in a sandwich ELISA
The detection antibody is released from the conjugate pad as soon as it comes
in contact with the analyte with IαIP. The sandwich of capture AB, IαIP and detection
AB becomes visible when DAB and HRP (with streptavidin) create a brown color.
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In this case, the R21 is not dried onto the nitrocellulose but stored in the
conjugate pad. Using the results of section 4.6 six different concentrations of
detection antibody in the 20wt. % Sugar Solution are tested to determine which
concentration provides the lowest signal to background noise ratio. The
concentrations are presented as ratios of the initial solution 1/5/10/25/50/100
µg/mL because the exact concentration of the stock solution was not known.
After the best R21 dilution rate is determined various HRP concentrations are
used to lower the background color and to strengthen the intensity of the brown
color detection spot.
3.7

Optimization of Conjugate Release
The detection antibody R21 is stored in the conjugate pad. Fridley et. al. [24],

Gerbers et. al. [19] and Föllscher et. al. [18] showed different strategies to facilitate
the release of stored antibodies in paper e.g. varying pad sizes, materials and sugar
concentration as well as several blocking steps. These experiments are conducted
using the new detection antibody R21 with biotin.
The lengths of the conjugate pads are varied to 4x5mm and 5x5mm. These two
pads are blocked using 10μl of Non‐Fat Milk blocker and dried at 37°C on hot plate.
The Non‐Fat Milk blocker is produced by mixing 1.1g of Non‐fat Milk powder in 22g
of PBST. Afterwards, they are treated using 10μl of a 20 wt.% sugar solution with
trehalose and sucrose in Non‐Fat Milk blocker. In the sugar solution the
concentration of R21 is kept constant 20vol. % and again dried on a hot plate at 37°C.
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Afterwards, 10 μl of 7 μg/mL of HRP is applied onto the conjugate pad so that the
HRP can connect to biotin on the R21. The next step is to wash out the HRP and with
the R21. Therefore at first 40μl of PBSx1 solution is applied onto pad. Next apply 30μl
of PBSx1 after moving the pad to the next spot on the blotting paper. Finally four
more additional washing steps are conducted with 20μl of PBSx1. The same
procedure is repeated for different materials (glass fiber with binder/without) but
regarding blocked pads and pads without blocking the first blocking step is not
conducted when a non‐blocked pad is tested. To induce the color change 10μl of DAB
are pipetted onto each spot where the conjugate pad is washed out. The detailed
amounts of fluids used are displayed in Table 3‐3
Table 3‐3: Detailed Treatment of Conjugate Pads
Treat
4x5
5x5
Binder
w/o
binder
Blocked
w/o
blocking

Blocking
10μl

Sugar with
R21 10μl

x

HRP 10μl

PBSx1
1x40μl
1x30μl
4x20μl

DAB 10μl

x

x

x

x
x
x
x
x

Besides geometry and blocking steps, Fridley et. al. [24] showed that sugar can
facilitate the release of antibodies from the conjugate pad. Therefore different sugar
concentrations are tested. Trehalose and Sucrose as well as a mixture of these two
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reagents are tested. Trehalose and Sucrose are tested in varying wt. % of
1/2/5/10/20 and the mixture of both in 5/10/20 concentrations.
The conjugate pads are also blocked with 10μl of Superblocker and dried at
37°C on a hot plate. Afterwards 10μl of the tested sugar solution is applied on the
pad in which 20vol. % of R21 is present and dried once again. The conjugate pad is
treated with HRP before it is placed onto the blotting paper. Then it is washed with
120μl of PBSx1 in 10μl steps. Finally 30μl of DAB is applied onto the spot where the
antibodies should be washed out.
3.8

Optimization of capture antibodies

In order to enable the highest possible sensitivity the stock solution of capture
antibodies were used for preparation of the detection area.
3.9

ELISA standard curve
The final goal is it to produce a standard curve in which the concentration of

IαIP is plotted over the intensity of the color spot. Therefore it is important for the
test to operate in the range of the natural concentration of IαIP in the blood which is
around 400‐800 μg/mL and further more at lower concentrations similar to cases
when sepsis is present. The limit of detection in the case of a sepsis test is not the
first priority, since the concentration of this protein is high compared to other ELISA
analytes leaving the LOD to be a less significant factor.
Experiments are performed with varying IαIP concentrations. Since the stock
solution has a concentration of 240µg/mL various dilutions will be tested.
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3.10 Effects of chemical Valve Reagents in the ELISA Test
As previously discussed the valve technology involves the use of certain chemical
reagents like A3CS and FC‐72 which are used for the hydrophobic layer and Tween 20
and Ethanol for manufacturing the surfactant paste. Since biological testing is
performed on the chips, the effects of these chemicals on the biology need to be
evaluated. Therefore concentrations used for the calibration curve are repeated
without using of valves. The reagents are applied manually by hand onto the chip.
The signal intensity for both cases (using valves/ not using valves) is measured and
compared.
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4
4.1

CHAPTER 4 ‐ FINDINGS
Influence of the viscosity of the opening times
The results of the experiments on the opening times of the valves with respect

to different plasma‐buffer concentrations can be seen in Figure 4‐1.
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Figure 4‐1: Opening Times for various plasma in buffer concentrations

The opening time of the valve changes with respect to the amount of
concentration of blood plasma in buffer. The higher the concentration of buffer is
correlated with a shorter opening time of the valve. Pure blood plasma needs around
8 min to open the valve whereas diluted blood plasma takes around 2min. The
conclusion is that the opening time of the valves is dependent on the concentration
of blood plasma in buffer. In other words, the opening time is related to the viscosity
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of the solution because pure plasma is not as viscous as diluted plasma. According to
Kamke et. al. [64] Blood plasma has a viscosity of 1.8η at 20°C whereas the viscosity
of PBS‐buffer is much smaller. The theoretical assumption that more PBS‐buffer
decreases the viscosity and therefore shortens the opening time was confirmed.
Further experiments have to show how much blood serum is needed to get a clear
color spot in the detection region.
4.2

Trypsin immobilization
The color change was confirmed when putting trypsin and BAPNA together in

viles. The results are pictured in Figure 4‐2. The left vial contains only trypsin and the
right vial is the reacted product.

Figure 4‐2: Color change in a vial using trypsin and BAPNA

It can be seen that there is a color change in the right vial. Trypsin changes its
color from clear to a bright yellow. This proves that when the two reagents are
brought together in solution a color change happens.
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In Figure 4‐3 the immobilization on nitrocellulose and blotting paper is
illustrated. The nitrocellulose paper circles are in the upper part of the picture and
the blotting paper circles are in the lower part. These circles have a diameter of
5mm.

Figure 4‐3: Immobilization of Trypsin on Nitrocellulose (Top) and Blotting Paper (bottom)

It can be seen that there is a slight color change at the outer ring on the
nitrocellulose. This phenomenon is known as the coffee ring effect. The solid
particles in this case trypsin are left over after the liquid evaporates. They form a ring
pattern which is visible after BAPNA gets in contact with trypsin as shown before. The
color change is not as strong as it is on the blotting paper where a clear color
gradient is visible. This is because of the smaller amount of fluids which are used
during testing. Of course the more trypsin that is immobilized on the paper will
increase the intensity of the color signal.
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Besides immobilizing trypsin onto nitrocellulose and blotting paper Figure 4‐4
shows the results of the attempt to immobilize trypsin onto glass fiber membrane
filters with and without binder.

Figure 4‐4: Trypsin Immobilization onto Membrane Filter without (top) and with (bottom) Binder

The amount of Trypsin increases from left to right but the volume of BAPNA is
kept constant at 12µl. The BAPNA is applied after the spot where trypsin is applied
completely dried out. This prevents the reaction from taking place in a wet
environment because trypsin is supposed to be dried onto the nitrocellulose
membrane.
The Glass Fiber Membrane Filters on which trypsin and BAPNA come together
are supposed to have increasing color intensity. More trypsin that is on the
membrane will create a stronger signal.
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Unfortunately, the color change is not very clear since the light yellow on white
paper can barely be seen which makes it hard determine a color change. For this
reason, the alternatives of DAB and HRP were investigated.
4.3

Vertical Test DAB
The vertical test is performed to show that the enzymatic reaction of DAB and

HRP is possible on paper. The findings are pictured in Figure 4‐5 and mathematically
analyzed in Figure 4‐6.

Figure 4‐5: DAB Vertical Test

Two concentrations are used for the HRP 1:6000 (bottom) and 1:8000 (top).
The color is slightly stronger using the higher concentration of HRP. The negative
control without HRP but with 20μl of DAB is lighter than the spot where 20 μl of both
reagents are used.
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The intensity is measured using ImageJ and compared with the standard white
blotting paper to have a reference. The results are plotted in Figure 4‐6.
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Figure 4‐6: Vertical Test DAB 1:6000/8000

It can be seen that the intensity of the color spot is decreasing with an
increasing amount of the two reagents. The 1:6000 curve is lower than the 1.8000
curve because a lower intensity corresponds to a darker spot. Since the
concentration of HRP is higher in 1:6000 the DAB has more molecules where a color
change can happen. The negative control where only DAB is pipetted on the spot is
necessary because the DAB substrate itself has a light brown color. Even when there
is no HRP the color spot becomes light brown. Due to the enzymatic reaction the
color spots gets darker than without the HRP. As one can see the 20μl negative
control line has a higher intensity in both cases as compared to the combination of
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20µl HRP and 20µl DAB. This proves that there is an enzymatic reaction on the
blotting paper.
4.4

Enzymatic Lateral Flow Test
The results of the enzymatic lateral flow test where HRP is immobilized onto

nitrocellulose are illustrated in Figure 4‐7. A constant volume of 70 μl DAB is pipetted
onto each spot.

Figure 4‐7: Lateral Flow Test Immobilized HRP

The presence of a dark brown color spot proves that it is possible to immobilize
HRP onto nitrocellulose. Higher concentrations of HRP result in darker color spot on
the nitrocellulose because there is more opportunity for DAB molecules to react with
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HRP. The brown color on the channels arises from the substrate DAB which flows
down these channels to reach the detection membrane. DAB has a light brown color
even when there is no enzymatic reaction.
Besides HRP, R21 with biotin is immobilized onto nitrocellulose. Figure 4‐8
shows the results of the lateral flow test.

Figure 4‐8: Immobilization of R21 onto Nitrocellulose

It is evident that R21 immobilization is successful. The color spot where the ABs
are immobilized is darker than the rest of the nitrocellulose. Even though the
background color is relatively high compared to the signal itself but it is still visible to
the naked eye.
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4.5

Optimization of Detection Antibody and amount of HRP

First the optimized concentration of R21 is presented and second the improved
concentration of R21 stored in the conjugate pad is presented. Additionally the
concentration of HRP is enhanced as well.
4.5.1 Directly Immobilized R21
The color intensity of the signal spot vs. background is measured for all five chips
using the software ImageJ. The inverse of Signal/Background is plotted over the
concentration of HRP in Figure 4‐9.
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Figure 4‐9: Optimization of R21 and HRP Signal/Background curve
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The graph shows that the lower concentrations of HRP in PBS result in better
Signal to noise ratio on the detection spot. This result is logical since lower amounts
of HRP on the background of the nitrocellulose result in less color induced by DAB.
However, there comes a point when the amount of HRP is too low to create a strong
enough signal on the color spot over that of the background. At this point the curve
decreases again. Future studies can optimize this topic. Besides the amount of HRP,
the dilution factor of R21 is optimized. Since ProThera Biologics© produce the
detection AB by tagging the enzyme biotin onto the AB they can’t tell the exact
concentration anymore. Therefore a dilution is more suitable than trying to
determine the concentration. Only one vial with detection antibody is used otherwise
there also might have been variation in the concentration in a batch of R21. In Figure
4‐10 the Inverse of Signal to noise is plotted over different dilution factors of R21 in
PBSx1.
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Figure 4‐10: Optimization of detection antibody

The graph shows that the lower the concentration of R21 in PBSx1 has a better
signal to noise ratio as the graph is slightly increasing. However, it cannot be
determined if the optimal concentration of R21 is the non‐diluted detection AB itself
or if the signal can be improved later on by producing a higher concentrated
detection AB.
4.5.2 R21 in a sandwich ELISA
Five different concentrations of HRP are tested to evaluate which is the most
effective dilution for the ELISA test. The proportion of Signal to Background is plotted
in Figure 4‐11 over the concentration.
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Figure 4‐11: Optimization of HRP complete ELISA

The concentration of 1µg/mL has the best signal to noise ratio whereas the two
results of the of the lowest concentration correlate to a spot which is almost invisible
due the dark background.
Various amounts of detection antibodies diluted in the sugar solution are
stored in the conjugate pad to be washed out from the analyte which is IαIP in PBSx1.
The results regarding the optimal signal to background proportion are displayed in
Figure 4‐12.
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Figure 4‐12: Optimization of R21 in the conjugate pad

It can be recognized that the optimal concentration of R21 in the sugar solution is
10µg/mL. This dilution provides the best Signal to Background proportion which
means that the intensity of the signal is strong but the background intensity is low in
comparison.
4.6

Optimization of Conjugate Release
The results of the conjugate pad release optimization are displayed in Figure

4‐13 to Figure 4‐16. Different materials, sizes and chemical treatments as well as
sugar blocking are tested in order to find the best design and pre‐treatment of the
conjugate pad used in the PBV.
In Figure 4‐13 the findings of two different pad sizes are illustrated. It can be
clearly seen that the 4x5mm conjugate pad releases the R21 detection antibody
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faster than a 5x5mm pad. The amount of fluid to wash out the antibodies is around
90μl for the small pad and around 150μl for the larger conjugate pad.
Size

40μl

30μl

20μl

20μl

20μl

20μl

4x5

5x5
Figure 4‐13: Different sizes of Conjugate Pads

One explanation for a better release of a smaller pad is the lower amount of
non‐specific binding of the detection antibody because the surface area is smaller in
comparison to a larger conjugate pad. The R21 cannot connect to as many paper
fibers as in the 5x5mm pad. Furthermore, the geometry of a quadratic conjugate pad
may affect the fluid flow more than just a rectangular shaped pad. The
miniaturization of a conjugate pad is limited because a smaller pad is more difficult to
handle in the assembly process. Therefore the chip is fabricated with a 4x5mm
conjugate pad.
Figure 4‐14 shows the impact of a blocking step before applying the 20 wt.%
sugar solution with detection antibody on the conjugate. The figure shows that the
detection antibody is released much quicker from the blocked pad than from the one
without a blocking step.
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Figure 4‐14: Different blocking of Conjugate Pads

The blocking step prevents antibodies from binding to a surface which
improves the signal to noise ratio as well as the release of antibodies. No interaction
with the conjugate surface facilitates their release.
The next test is performed using conjugate pads with and without binders
(Figure 4‐15). The paper with binder releases the detection antibody much better
than the paper without binder. The prevention of non‐specific binding in the
conjugate seems to be an appropriate way to facilitate antibodies release.
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20μl
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20μl

20μl

w/o
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With
binder
Figure 4‐15: Different Conjugate Pad Materials

The use of sugar e.g. trehalose and sucrose facilitates the release in conjugate
pads enormously. Therefore, five different concentrations and three different
mixtures are tested. The results are displayed in Figure 4‐16.
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Figure 4‐16: Conjugate release using varying sugar concentrations

The 20wt. % mixture of the two sugar components seems to have the best
improvement regarding the color intensity of the spot. This means a good release of
the antibodies. Nevertheless the intensity of the color spots is very low which let to
use a greyscale picture in order to determine the best result more easily.
Stevens et. al. [48] remarked that trehalose and sucrose molecules substitute
for the water hydroxyl groups which are lost after drying. When fluid runs over the
dried proteins hydroxyl group re‐substitute for the sugar again allowing for a higher
yield in releasing the proteins.
ImageJ is used to determine the mean intensities of the color spots. The
intensities are plotted over the sugar concentrations in Figure 4‐17. Additionally
curves are calculated to the fit in the best way.
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Figure 4‐17: Optimization of varying sugar concentrations

The non‐linear fit for the trehalose/ sucrose mix is illustrated in equation (4).

41.98

.

167.92

(4)

This equation is used to calculate the intensity for a theoretical optimal sugar
concentration. At the point of the optimal concentration, the x‐value becomes 100
assuming that the pure sugar mixture is used. This value is compared to the value of
a 20wt. % sugar solution. The improvement is around 1.5%.
X=20

X=100

Improvement [%]

170.487

167.926

1.502
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The sugar solution is restricted to amounts higher than 20wt. % otherwise the
fluid is very viscous which makes it hard to handle this solution which led to the
decision to use a 20wt. % sugar solution.
4.7

Proof of Concept
To prove the concept of a fluidic circuit which is capable of loading fluids

sequentially, a chip is run with food color. The picture sequence in Figure 4‐18 proves
that two fluids are sequentially loaded.

T=0s

T=30s

T=60s

T=300s

T=310s

T=600s

Figure 4‐18: Sequential Loading of the Fluids

The two reagents (yellow and green food colored water) which need to be
triggered are stored in the two inlets beside the main channel. The valves hold the
reagents back until the surfactant is dissolved. Next, the sample is applied on the
main spot. It runs down the main channel as well as into the second layer. Dissolving
the surfactant the yellow reagent comes up first to the main channel and runs down
to the absorption area and second, the green reagent is triggered in the same way. It
can be seen that the fluids are triggered in the correct sequence. This ensures that
later on the whole amount of reagent can react with the test spot.
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4.8

Complete ELISA test

Figure 4‐19 shows that the ELISA test is working because a brown dot is visible on the
detection membrane. The bottom right corner of every batch of six chips is the
negative control where no capture antibodies are immobilized onto the nitrocellulose
membrane. No color spot is visible.

Figure 4‐19: ELISA test

In case of the left chip the reagents are pipetted manually onto the chip
whereas the right chip is run without any interaction after the reagents were applied
onto the chip. The next step is to use varying concentrations of IαIP to create a
standard curve.
4.9

ELISA standard curve
In Figure 4‐20 the Signal Background proportion is plotted over different

concentrations of IαIP. The lower the concentration of IαIP is the lower is proportion
of Signal to Background.
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Figure 4‐20: IαIP Standard Curve

This curve makes it possible to run a paper based ELISA with IαIP. After
estimating the intensity of the detection spot and the background the curve makes it
possible to find the concentration of the analyte. The concentrations which are used
to create the standard curve are in a range of 800 to 25 ng/mL, but in the human
body the concentration is around 800 to 200 µg/mL. In this study of IαIP LOD is not
the primary goal to find because the concentration of the test analyte is three orders
of magnitude lower than the actual concentration of IαIP in human blood.
Table 4‐1 show the decreasing intensity of the ELISA sandwich spots (brown
dot). An ELISA sandwich cannot be formed without IαIPs which means a lower
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concentration results in a less intensive color spot because unbound detection
antibodies are washed away. The detection antibody itself cannot bind directly to the
capture antibody 69.26. The products of the enzymatic reaction are rinsed into the
absorption area.
Table 4‐1: Detection Spots

800

400

200

100

50

25

c(IαIP)
ng/mL

4.10 Effects of chemical Valve Reagents in the ELISA Test
The proposed standard curve is produced with the paper chip with its fluidic
valve technology which autonomously triggers the reagents when they are needed.
All of the reagents are applied manually on the chip at the right time. The obtained
results are the same.
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5

CHAPTER 5 – CONCLUSION
The experiments show the development of a paper‐based device which is able to

perform an ELISA autonomously after the reagents needed are applied onto the
device. The transfer from a microtiter‐plate ELISA onto paper is proved. All criteria of
POC device e.g. low cost, low fluid volumes, sustainable and rapid testing are met.
The overall test time for microtiter‐plates which is around several hours is reduced to
minutes disregarding the assembly process of the device itself.
Research is conducted regarding LOD, optimal assay concentrations as well as
reproducibility. Starting from simple spot test with two different approaches (BAPNA
and trypsin or HRP and DAB) the more promising HRP and DAB enzymatic reaction
was chosen. The ELISA is split up into single parts which are conducted successfully
on their own. The conjugate release is optimized using different materials, sizes as
well as a sugar solution which facilitates the release of the detection AB. Afterwards
all parts were put together to perform a complete ELISA on paper.
The final result is a standard curve where the intensity of the ELISA result in form
of a color spot is plotted over the concentration of IαIP in a buffer sample..
5.1

Recommendation and Future Work
In the following abstract future directions of research are discussed to improve

the usage of paper based microfluidic devices in biological testing. So far microtiter
plates still have a lower limit of detection. The goal is to produce a paper chip which
has the same LOD as a 96‐well ELISA. Besides improvements regarding parts of the
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chip a different method to detect the concentration of IαIP is presented. In the case
not an ELISA but an enzymatic test is conducted. The advantages are that the color
difference of two detection areas is measured to determine the amount of IαIP by
referring the concentration to the color intensity difference.
5.1.1

Two Way Circuit
Besides the presented ELISA test further experiments should be conducted

using trypsin and BAPNA to perform not an ELISA but an enzymatic assay. In Figure
5‐1 the schematic of the enzymatic assay reaction is illustrated. The reaction takes
place on the nitrocellulose of the chip. In the first step trypsin (blue tile) which
represents the capture antibody is immobilized on the nitrocellulose membrane
(gray‐shaded area).

Figure 5‐1: Schematic of the enzymatic assay for the detection of IαIP’s

Due to the electrostatic forces of the membrane trypsin can easily be bonded
onto the surface. Trypsin is only applied in the center of the detection spot so that
most of the membrane is not covered with trypsin and is still active. These areas have
to be blocked with the blocking reagent bovine serum albumin (BSA) (grey circles) to
inactivate them in the second step. After that other proteins cannot bind to other
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regions but can connect to the trypsin. As previously discussed antibodies or antigens
can only bind to the specific counterpart of themselves with respect to the key‐lock
principle. In the third step the sample runs over the detection area and IαIP’s (brown
tiles) can bind only to the immobilized trypsin. In the next step, a chromogenic
substrate (BAPNA) runs over the membrane (grey hash). This causes a color change
of the detection spot to yellow. The more IαIP’s connects to the trypsin the lower the
color intensity of the spot becomes because less substrate can bind to free trypsin
particles. Finally a stop solution such as Basic Pancreatic Trypsin inhibitor (BPTI) flows
over the test spot (white dotted hash) and deactivates the remaining enzymes and
quenches further development of the color change. This step can be left out since
the chip stop its reaction when all fluid ran over the detection spot.
The developed two way circuit has two ways and in total three nitrocellulose
spots: Two detection membranes and one filter membrane. The detection
membranes work as discussed before. The filter membrane is different because it has
monoclonal antibodies 69.26/69.31 instead of trypsin immobilized on the
nitrocellulose to capture only IαIP’s. The two detection areas should develop altering
intensities because on one side no IαIPs are presented anymore since they are
filtered on the monoclonal antibody nitrocellulose. Figure 5‐2 illustrates the
proposed two way fluidic circuit which is able to compare two samples.
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Figure 5‐2: Two Way Circuit using Trypsin and BAPNA

The solution with IαIPs is applied on the top spot of the chip. It divides its flow‐
One part of the solutions runs over the Filter and later on to the Detection Area. The
other flows down directly to the Nitrocellulose. Meanwhile the surfactant part of the
valves which are positioned under the two fluid storage area are reached. The fluid
opens the valves as soon as the complete solution runs over the chip. BAPNA
connects to the remaining immobilized trypsin particles and induces a color change.
The more IαIPs are present on the nitrocellulose the less intensive is the signal.
Therefore the yellow on the filtered spot should be brighter than on the unfiltered
spot. Optional is the stop solution which ends the enzymatic reaction but this step
might be eligible to be left out. Instead a wash step could be added to produce a
clearer signal. The detailed flow of the fluids is shown in Figure 5‐3. Due to the
symmetry of the chip the fluid flow is displayed on only one side of the chip.
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Figure 5‐3: Two Way Circuit Detailed Flow

Gerbers et. al. [19] and Föllscher et. al. [18] figured out that the yield of the chips
is increased when they are placed in a housing. Connections between different
materials of the chip are facilitated. Figure 5‐4 displays the housing of the two way
circuit where the left picture is the top of the housing and the right figure sows the
bottom of the housing.
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Figure 5‐4: Housing for the Two Way Circuit

Three cutouts are made for the fluid storage in the center of the chip and three
more for the detection areas of the chip as well as the proposed filter for IαIP. Right
before and after these areas little pins ensure the connection between the wax paper
channel and the nitrocellulose paper. The half‐moon extrusions are placed in the
housing to eliminate the possibilities of an air gap between the different layers of the
valve. The bottom part of the housing acts as a base which presses the chip together.
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5.2

Optimization of Valve components
The valve mentioned in the thesis is proposed as a unique part of the PBD

which makes it possible to sequentially load the fluids at the right time. This valve is
the most important part because having a valve which opens too early the order of
the ELISA is not correct anymore. As a result no or a worse result can be obtained.
Spreading the hydrophilic and surfactant paste into the holes of the tape by hand
causes different amounts of paste every time. This affects the opening time of the
valves as well as the time fluid needs to bridge the layers. Developing a better way to
spread a constant volume of paste in the holes of the chip is the key to a higher yield
performing tests with PBD. Pre‐producing the paste as a pellet which is afterwards
placing in the hole would ensure a constant amount of reagents needed to form a
paper valve. Another possibility is to mix the paste in a syringe and to inject a certain
amount of wet paste which is afterwards formed to a circular pellet.
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